Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Patent
1996-12-26
1999-03-02
LeGuyader, John L.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
435 6, 435 9131, 4351723, 4353201, 536 231, 536 232, 536 245, C12Q 168, C07H 2104
Patent
active
058770224
ABSTRACT:
Enzymatic RNA molecules which cleave apo(a) mRNA.
REFERENCES:
patent: 4987071 (1991-01-01), Cech et al.
Berg, "A New Serum Type in Man--the LP System," Acta Pathol. Microbiol. Scand. 59:369-382 (1963).
Chen et al., "Multitarget-Ribozyme Directed to Cleave at up to Nine Highly Conserved HIV-1 env RNA Regions Inhibits HIV-1 Replication-Potential Effectiveness Against Most Presently Sequenced HIV-1 Isolates," Nucleic Acids Research 20:4581-4589 (1992).
Chowrira and Burke, "Extenssive Phosphorothioate Substitution Yields Highly Active and Nuclease-Resistant Hairpin Ribozymes," Nucleic Acids Res. 20:2835-2840 (1992).
Christofferson et al., "Application of computational technologies to ribozyme biotechnology products," Journal of Molecular Structure (Theochem) 311:273-284 (1994).
Collins and Olive, "Reaction Conditions and Kinetics of Self-Cleavage of a Ribozyme Derived From Neurospora VS RNA," Biochemistry 32:2795-2799 (1993).
Dropulic et al., "Functional Characterization of a U5 Riboyme: Intracellular Suppression of Human Immunodeficiency Virus Type I Expression," Journal of Virology 66:1432-1441 (1992).
Elroy-Stein and Moss, "Cytoplasmic Expression System Based on Constitutive Synthesis of Bacteriophage T7 RNA Polymerase in Mammalian Cells," Proc. Natl. Acad. Sci USA 87:6743-6747 (1990).
Friedman, "Progress Toward Human Gene Therapy," Science 244:1275-1281 (1989).
Gao and Huang, "Cytoplasmic Expression of a Reporter Gene by Co-Delivery of T7 RNA Polymerase and T7 Promoter Sequence with Cationic Liposomes," Nucleic Acids Res. 21:2867-2872 (1993).
Gonzalez-Gronow et al., "Further Characterization of the Cellular Plasminogen Binding Site: Evidence that Plasminogen 2 and Lipoprotein a Complete for the Same Site," Biochemistry 28:2374-2377 (1989).
Guerier-Takada et al., "The RNA Moiety of Ribonuclease P Is the Catalytic Subunit of the Enzyme," Cell 35:849-85 (1983).
Gurakar et al., "Levels of Lipoprotein Lp(a) Decline with Neomycin and Niacin Treatment," Atherosclerosis 57:293-301 (1985).
Hajjar et al., "Lipoportein(a) modulation of endothelial cell surface surface fibrinolysis and its potential role in atherosclerosis," Nature 339:303-305 (1989).
Hampel et al., "`Hairpin` Catalytic RNA Model: Evidence for Helices and Sequence Requirement for Substrate RNA," Nucleic Acids Research 18:229-304 (1990).
Hampel and Tritz, "RNA Catalytic Properties of the Minimum (-)s TRSV Sequence," Biochemistry 28:4929-4933 (1989).
Haseloff and Gerlach, "Simple RNA Enzymes with New and Highly Specific Endoribonuclease Activities," Nature 334:585-591 (1988).
Hertel et al., "Numbering System for the Hammerhead," Nucleic Acids Res. 20:3252 (1992).
Jaeger et al., "Improved Predictions of Secondary Structures for RNA," Proc. Natl. Acad. USA 86:7706-7710(1989).
Jeffries and Symons, "A Catalytic 13-mer Ribozyme," Nucleic Acids Research 17:1371-1377 (1989).
Kashani-Sabet et al., "Reversal of the Malignant Phenotype by an Anti-ras Ribozyme," Antisense Research & Development 2:3-15 (1992).
L'Huillier et al., "Cytoplasmic Delivery of Ribozymes Leads to Efficient Reduction in .alpha.-Lactalbumin mRNA Levels in C1271 Mouse," Embo J. 11:4411-4418 (1992).
Lawn et al., "Atherogenesis in transgenic mice expressing human apolipoprotein(a)," Nature 360:670-672 (1992).
Leren et al., "Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia," Atherosclerosis 73:135-141 (1988).
Lieber et al., "Stable High-Level Gene Expression in Mammalian Cells by T7 Phage RNA Polymerase," Methods Enzymol. 217:47-66 (1993).
Lisiewicz et al., "Inhibition of Human Immunodeficiency Virus Type 1 Replication by Regulated Expression of a Polymeric Tat Activation Response RNA Decoy as a Strategy for Gene Therapy in AIDS," Proc. Natl. Acad. Sci. U.S.A. 90:8000-8004 (1993).
McLean et al., "cDNA sequence of human apolipoprotein(a) ishomologous to plasminogen," Nature 330:132-137 (1987).
Miles et al., "A potential basis for the thrombotic risks associated with lipoprotein(a)," Nature 339:301-303 (1989).
Moliterno et al., "Relation of Plasma Lipoprotein(a) to Infarct Artery Patency in Survivors of Myocardial Infarction," Circulation 88:935-940 (1993).
Ohkawa et al., "Activities of HIV-RNA Targeted Ribozymes Transcribed From a `Shot-Gun` Type Ribozyme-trimming Plasmid," Nucleic Acids Symp. Ser. 27:15-16 (1992).
Ojwang et al., "Inhibition of Human Immunodficiency Virus Type 1 Expression by a Hairpin Ribozyme," Proc. Natl. Acad. Sci. USA 89:10802-10806 (1992).
Perreault et al., "Relationship between 2'-Hydroxyls and Magnesium Binding in the Hammerhead RNA Domain: A Model for Ribozyme Catalysis," Biochemistry 30:4020-4025 (199.
Perrotta and Been, "Cleavage of Oligoribonucleotides by a Ribozyme Derived from the Hepatitis .delta. Virus RNA Sequence," Biochemistry 31:16-21 (1992).
Pieken et al., "Kinetic Characterization of Ribonuclease-Resistant 2'-Modified Hammerhead Ribozymes," Science 253:314-317 (1991).
Roemer and Friedman, "Concepts and strategies for human gene therapy," Eur. J. Biochem. 208:211-225 (1992).
Rossi et al., "Ribozymes as Anti-HIV-1 Therapeutic Agents: Principles, Applications, and Problems," Aids Research and Human Retroviruses 8:183-189 (1992).
Rubino et al., "Nucleotide sequence and structural analysis of two satellite RNA associated with chicory yellow mottle virus," J. General Virology 71:1897-1903 (1990).
Sarver et al., "Catalytic RNAs (Ribozymes): A New Frontier in Biomedical Applications," AIDS Res. Revs. 2:259-285 (1992).
Saville and Collins, "A Site-Specific Self-Cleavage Reaction Performed by a Novel RNA In Neurospora Mitochondria," Cell 61:685-696 (1990).
Saville and Collins, "RNA-Mediated Ligation of Self-Cleavage Products of a Neurospora Mitochondrial Plasmid Transcript," Proc. Natl. Acad. USA 77:8826-8830 (1991).
Scanlon et al., "Ribozyme-Mediated Cleavage of c-fos mRNA Reduces Gene Expression of DNA Synthesis Enzymes and Metallothionein," Proc. Natl. Acad. Sci. USA 88:10591-10595 (1991).
Scanu et al., "Lipoprotein(a) and Atherosclerosis," Annals of Internal Medicine 115:209-218 (1991).
Scaringe et al., "Chemical synthesis of biologically active oligoribonucleotides using .beta.-cyanoethyl protected ribonucleotide phosphoramisdites," Nucl Acids Res. 18:5433-5441 (1990).
Scott, "Lipoprotein(a): Thrombotic and atherogenic," BMJ 303:663-664 (1991).
Stull and Szoka, "Antigene, Ribozyme and Aptamer Nucleic Acid Drugs: Progress and Prospects," Pharmaceutical Research 12:465-483 (1995).
Symons, "Ribozymes," Current Opinion in Structural Biology 4(3):322-330 (1994).
Taira et al., "Construction of a novel RNA-transcript-trimming plasmid which can be used both in vitro in place of run-off and (G)-free transcriptions anad in vivo as multi-sequences transcription vectors," Nuclei Acids Research 19:5125-5130 (1991).
Textbook of Medical Physiology, Guton, A.C., Saunders Company, Philadelphia pp. 761-764 (1991).
Tomlinson et al.m "Rhesus Monkey Apolipoprotein(a)," J. Biol. Chem. 264:5957-5965 (1989).
Uhlenbeck, "A Small Catalytic Oligoribonucleotide," Nature 328:596-600 (1987).
Usman et al., "Automated Chemical Synthesis of Long Oligoribonucleotides Using 2'-O-Silylated Ribonucleotide 3'-O-Phosphoramidites on a Controlled-Pore Glass Support: Synthesis of a 43-Nucleotide Sequence Similar to the 3'-Half Molecule of an Escherichis coli Formylmethoionine tRNA," J. Am. Chem. Soc. 109:7845-7854 (1987).
Usman and Cedergren, "Exploiting the chemical synthesis of RNA," TIBS 17:334-339 (1992).
Utermann "The Mysteries of Lipoprotein(a)," Science 246:904-910(1989).
Ventura et al., "Activation of HIV-Specific Ribozyme Activity by Self-Cleavage," Nucleic Acids Research 21:3249-3255 (1993).
Weerasinghe et al., "Resistance to Human Immunodeficiency Virus Type 1 (HIV-1) Infection in Human CD4.sup.+ Lymphocyte-Derived Cell Lines Conferred by Using Retroviral Vectors Expressing and HIV-1 RNA-Specific Ribozyme," Journal of Virology 65:5531-5534 (1994).
Williams et al., "Occlusive Arterial Thrombosis in Cynomolgus Monkeys with Varying Plasma Concentrations of Lipopr
McSwiggen James
Newton Roger S.
Ramharack Randy
Stinchcomb Dan T.
LeGuyader John L.
Ribozyme Pharmaceuticals, Inc
Warner Lambert
LandOfFree
Ribozymes targeted to APO(a) RNA does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ribozymes targeted to APO(a) RNA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ribozymes targeted to APO(a) RNA will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-422130